Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REFERENCES<br />
Rifat S. L., Eastwood M. R., Crapper McLachlan D. R. and Corey P. N. (1990) Effect <strong>of</strong> exposure<br />
230<br />
<strong>of</strong> m<strong>in</strong>ers to <strong>alum<strong>in</strong>ium</strong> powder. Lancet 336, 1162–1165.<br />
Rippon G. A. and Marder K. S. (2005) Dementia <strong>in</strong> Park<strong>in</strong>son's disease. Adv. Neurol. 96, 95–113.<br />
Roberts E. (1986) Alzheimer’s disease may beg<strong>in</strong> <strong>in</strong> the nose and may be caused by<br />
alum<strong>in</strong>osilicates. Neurobiol. Ag<strong>in</strong>g 7, 561–567.<br />
Rodrigues R. W., Gomide V. C. and Chadi G. (2001) Astroglial and microglial reaction after a<br />
partial nigrostriatal degeneration <strong>in</strong>duced by the striatal <strong>in</strong>jection <strong>of</strong> different doses <strong>of</strong> 6-<br />
hydroxydopam<strong>in</strong>e. Int. J. Neurosci. 109, 91–126.<br />
Rodriguez M. C., Obeso J. A. and Olanow C.W. (1998) Subthalamic nucleusmediated<br />
excitotoxicity <strong>in</strong> Park<strong>in</strong>son’s disease: a target for neuroprotection. Ann. Neurol. 44, S175–<br />
188.<br />
Rodríguez-Díaz M., Abdala P., Barroso-Ch<strong>in</strong>ea P., Obeso J. and González-Hernández T. (2001)<br />
Motor behavioural changes after <strong>in</strong>tracerebroventricular <strong>in</strong>jection <strong>of</strong> 6-hydroxydopam<strong>in</strong>e<br />
<strong>in</strong> the rat: an animal model <strong>of</strong> Park<strong>in</strong>son's disease. Behav. Bra<strong>in</strong> Res. 122, 79–92.<br />
Rodriguez M., Barroso-Ch<strong>in</strong>ea P., Abdala P., Obeso J. and Gonzalez-Hernandez T. (2001)<br />
Dopam<strong>in</strong>e cell degeneration <strong>in</strong>duced by <strong>in</strong>traventricular adm<strong>in</strong>istration <strong>of</strong> 6-<br />
hydroxydopam<strong>in</strong>e <strong>in</strong> the rat: similarities with cell loss <strong>in</strong> Park<strong>in</strong>son’s disease. Exp. Neurol.<br />
169, 163–181.<br />
Rodriguez-Pallares J., Parga J. A., Muñoz A., Rey P., Guerra M. J., Labandeira-Garcia J. L. (2007)<br />
Mechanism <strong>of</strong> 6-hydroxydopam<strong>in</strong>e <strong>neurotoxicity</strong>: the role <strong>of</strong> NADPH oxidase and microglial<br />
activation <strong>in</strong> 6-hydroxydopam<strong>in</strong>e-<strong>in</strong>duced degeneration <strong>of</strong> dopam<strong>in</strong>ergic neurons. J.<br />
Neurochem. 103, 145–156.<br />
Roedter A., W<strong>in</strong>kler C., Samii M., Walter G. F., Brandis A. and Nikkhah G. Comparison <strong>of</strong><br />
unilateral and bilateral <strong>in</strong>trastriatal 6-hydroxydopam<strong>in</strong>e-<strong>in</strong>duced axon term<strong>in</strong>al lesions:<br />
evidence for <strong>in</strong>terhemispheric functional coupl<strong>in</strong>g <strong>of</strong> the two nigrostriatal pathways. J.<br />
Comp. Neurol. 432, 217–229.